Tuesday 3 November 2026
Export CNC’s income statement to Excel — free account
Centene Corporation
CNC Healthcare Healthcare Plans
Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024.
- Revenue
- +1.93%
- EPS
- +99.0%
- Free cash flow
- −437.4%
- Total debt
- −11.6%
Quarter to September 2026, against a year earlier
66.49
1.96
−2.86%
Follow CNC
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
8 | 6 | 6 | 5 |
+8 more TTM periods Free account |
| 6.74% | (20.35%) | (26.03%) | (28.69%) | ||
| 1.81% | (6.02%) | (7.66%) | (8.38%) | ||
ROIC |
4.42% | (30.17%) | (32.27%) | (27.84%) | |
Return on Tangible Assets |
17.17% | (63.31%) | (91.61%) | (117.31%) | |
Average Days of Receivables |
36.39 | 32.51 | 35.79 | 33.93 | |
Free Cash Flow per Share |
7.98 | 18.13 | 14.45 | 8.76 | |
Free Cash Flow |
3,943.00 | 8,951.00 | 7,112.00 | 4,321.00 | |
Capital Expenditures |
(781.00) | (798.00) | (832.00) | (767.00) | |
| Other line items | |||||
Cash ROIC |
6.42% | 13.60% | 11.54% | 7.48% | |
Accounts Receivable Turnover |
9.39 | 10.24 | 9.46 | 10.30 | |
Accounts Payable Turnover |
11.63 | 11.88 | 11.95 | 13.42 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
30.01 | 35.05 | 33.41 | 27.83 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.24) | 0.10 | 0.01 | (0.01) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.43% | 6.41% | 6.54% | 6.63% | |
Share Based Compensation of Revenue |
0.12% | 0.12% | 0.11% | 0.10% | |
Interest Coverage |
1.59 | (8.61) | (10.86) | (11.24) | |
Operating CF/Net income |
3.24 | (1.91) | (1.23) | (0.76) | |
Depreciation/Fixed assets |
0.58 | 0.59 | 0.60 | 0.63 | |
Capex/Depreciation |
(0.64) | (0.64) | (0.66) | (0.60) | |
Revenue per Share |
412.62 | 410.96 | 402.59 | 394.99 | |
Operating CF per Share |
9.56 | 19.74 | 16.14 | 10.32 | |
Capex per Share |
(1.58) | (1.62) | (1.69) | (1.56) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026